Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1

Details for Australian Patent Application No. 2005244851 (hide)

International Classifications

Event Publications

9 November 2006 PCT application entered the National Phase

PCT publication WO2005/112885 Priority application(s): WO2005/112885

26 August 2010 Application Accepted

Published as AU-B-2005244851

7 October 2010 Assignment before Grant

Children's Hospital of Pittsburgh; Baxter Healthcare S.A.; Baxter International Inc. The application has been assigned to Baxter Healthcare S.A.; Baxter International Inc.; University Of Pittsburgh - Of the Commonwealth System Of Higher Education

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.